BSEInsider Trading / SAST2h ago · 25 Sept 2026, 05:06 pm

Closure of Trading Window

Novyra Pharmachem Ltd · 519353

✦ AI Summary

Novyra Pharmachem Ltd has closed its trading window for insiders from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter ended September 30, 2026, in compliance with SEBI regulations.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Novyra Pharmachem Ltd - 519353 - Closure of Trading Window

Attachments (1)

📄

7cd50e63-71b9-4dc3-bf04-b228ecbba244.pdf

pdf

Download →
View document text
NOVYRA PHARMACHEM LIMITED CIN NO. :- L21001GJ1987PLC171085 25t September, 2026 The General Manager-Listing Corporate Relationship Department The BSE Limited Ground Floor, PJ Towers, Dalal Street, Mumbai-400001 Scrip Code: 519353 Dear Sir/Madam, Subject: Intimation for Closure of Trading Window for the Quarter ended September 30, 2026 This is to inform you that the Company is closing its Trading window for dealing in the securities of the Company by the Promoters, members of the Promoter Group, Directors, KMPs, Insiders, Designated and Connected persons and their immediate relatives from Thursday, October 1, 2026 till 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended September 30, 2026 pursuant to the provisions of the Clause 4(2) of Schedule B read with Regulation 9 of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (as amended from time to time) and SEBI Circular No. SEBI/HO/ISD/ISD-SEC-4/P/CIR/2022/107 dated August 5, 2022 and SEBI/HO/ISD/ISD-PoD-2/P/CIR/2023/124 dated July 19, 2023 read with Company’s “Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities by Designated Persons” (“Insider Trading Code™). Accordingly, all the Designated persons (including dependants and immediate relatives as per code) and connected persons are advised not to enter into any transaction involving the securities of the Company during the aforesaid period of closure of trading window. The date of the Board Meeting in connection with publishing its Unaudited Financial Results for the quarter ended September 30, 2026 will be announced in due course. You are requested to take the same on record. Thanking You. Yours Faithfully, For, Novyra Pharmachem Limited (formerly known as Bansisons Tea Industries Ltd ) For, Novyra Pharmachem Limited froiy o frmelify i utho. Signator Anil \'{gxcatgrll\‘/\lohanb ai Anynreliya Director DIN : 11339148 RS No. 432, T P Scheme No. 3, F P No. 89/A, City Survey No. 3763, Plot No. C, Palky Plot No. A, Ground Floor, Back Side, Pavthawala Compound, B/h Zenith Mill, Vasta Devdi Road, Surat- 395004, Gujarat, India